Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 4:15 pm Purchase | 13D | VACCINEX INC VCNX | FCMI Parent Co. | 6,668,906 40.8% | 1,655,172 (+33.01%) | View |
| 2024-02-12 4:22 pm Purchase | 13D | VACCINEX INC VCNX | Zauderer Maurice | 2,500,771 14.4% | 966,447 (+62.99%) | View |
| 2024-02-09 4:08 pm Purchase | 13G | VACCINEX INC VCNX | Point72 Asset Management L.P. | 5,793,452 9.9% | 5,793,452 (New Position) | View |
| 2024-02-07 6:55 pm Purchase | 13G | VACCINEX INC VCNX | HIRSCHMAN ORIN | 1,247,061 9.9% | 13,679 (+1.11%) | View |
| 2023-10-18 4:15 pm Purchase | 13D | VACCINEX INC VCNX | FCMI Parent Co. | 5,013,734 40.1% | 5,013,734 (New Position) | View |
| 2023-10-12 4:30 pm Purchase | 13D | VACCINEX INC VCNX | Zauderer Maurice | 1,534,324 11.8% | 1,010,000 (+192.63%) | View |
| 2023-10-11 12:28 pm Purchase | 13G | VACCINEX INC VCNX | HIRSCHMAN ORIN | 1,233,382 9.9% | 1,233,382 (New Position) | View |
| 2023-09-26 4:15 pm Purchase | 13D | VACCINEX INC VCNX | Zauderer Maurice | 524,324 10.8% | 524,324 (New Position) | View |
| 2023-05-25 4:31 pm Purchase | 13D | VACCINEX INC VCNX | FCMI Parent Co. | 30,205,986 46.3% | 6,711,552 (+28.57%) | View |
| 2023-04-05 4:30 pm Purchase | 13D | VACCINEX INC VCNX | FCMI Parent Co. | 23,494,434 42.8% | 4,146,341 (+21.43%) | View |
| 2022-11-29 4:31 pm Purchase | 13D | VACCINEX INC VCNX | FCMI Parent Co. | 19,348,093 38.8% | 3,778,575 (+24.27%) | View |
| 2022-11-28 4:31 pm Purchase | 13D | VACCINEX INC VCNX | Zauderer Maurice | 5,055,305 10.1% | 1,511,430 (+42.65%) | View |
| 2022-02-14 10:29 am Purchase | 13D | VACCINEX INC VCNX | FCMI Parent Co. | 15,569,518 36.5% | 3,603,602 (+30.12%) | View |
| 2022-02-10 5:15 pm Purchase | 13D | VACCINEX INC VCNX | Zauderer Maurice | 3,543,875 8.3% | 3,543,875 (New Position) | View |
| 2021-02-16 3:34 pm Sale | 13G | VACCINEX INC VCNX | Point72 Asset Management L.P. | 0 0% | -1,425,000 (Position Closed) | View |
| 2021-02-12 4:35 pm Sale | 13G | VACCINEX INC VCNX | MSD Partners L.P. | 0 0% | -1,225,490 (Position Closed) | View |
| 2020-10-19 10:28 am Purchase | 13G | VACCINEX INC VCNX | Aberdeen Foundation | 1,895,580 9.4% | 1,895,580 (New Position) | View |
| 2020-07-16 5:27 pm Purchase | 13G | VACCINEX INC VCNX | Point72 Asset Management L.P. | 1,425,000 7.2% | 1,425,000 (New Position) | View |
| 2020-07-16 12:22 pm Purchase | 13D | VACCINEX INC VCNX | FCMI Parent Co. | 11,965,916 58.7% | 1,156,031 (+10.69%) | View |
| 2020-01-27 12:32 pm Purchase | 13D | VACCINEX INC VCNX | FCMI Parent Co. | 10,809,885 58.5% | 982,318 (+10.00%) | View |